New drug ORN252 put to the test in healthy volunteers
Knowledge-focused
Recruiting now
This early-stage study is testing the safety and tolerability of a new drug called ORN252 in 20 healthy adults. Researchers will monitor for side effects and measure how the drug moves through the body. The goal is to gather safety information, not to treat any disease.
Phase: PHASE1 • Sponsor: Orna Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC